Avenue Therapeutics, Inc. Stock
Stocks
ATXI
US05360L4032
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
11:06:17 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.4076 USD | +13.22% |
|
-18.48% | -40.08% |
| Market Cap | 1.34M 1.19M 1.11M 1.02M 1.91M 129M 1.93M 13.48M 5.22M 66M 5.04M 4.93M 212M | P/E 2024 |
-0.22x | P/E 2025 | -0.73x |
|---|---|---|---|---|---|
| Enterprise Value | -1.51M -1.34M -1.25M -1.14M -2.16M -145M -2.18M -15.17M -5.88M -74.31M -5.68M -5.55M -238M | EV / Sales 2024 |
-
| EV / Sales 2025 | -491,128x |
| Free-Float |
86.49% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +13.22% | ||
| 1 week | -18.48% | ||
| Current month | +1.90% | ||
| 1 month | -28.49% | ||
| 3 months | +33.64% | ||
| 6 months | +16.46% | ||
| Current year | -40.08% |
| 1 week | 0.27 |  | 0.49 |
| 1 month | 0.25 | | 0.9 |
| Current year | 0.15 | | 0.9 |
| 1 year | 0.15 | | 0.97 |
| 3 years | 0.15 | | 52.88 |
| 5 years | 0.15 | | 2,081.25 |
| 10 years | 0.15 | | 13,882.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 2022-07-31 | |
David Jin
CEO | Chief Executive Officer | 36 | 2022-03-30 |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 2015-02-08 | |
Neil Herskowitz
BRD | Director/Board Member | 69 | 2015-07-31 |
Jay Kranzler
CHM | Chairman | 68 | 2023-03-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/2/26 | Free | Company | 111,209 | 3.4934% | ||
| 3/31/25 | Free | Company | 33,724 | 1.6419% | ||
| 12/31/24 | Other | Company | 294,800 | 15.4214% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +13.22% | -18.48% | -41.77% | -99.22% | 1.34M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +20.19% | +81.44% | 57.39B | |
| +0.89% | -0.63% | +2.17% | +36.19% | 47.64B | |
| +0.36% | +0.81% | +342.39% | +742.40% | 44.29B | |
| -0.96% | -4.50% | +24.96% | +35.38% | 42.5B | |
| -0.20% | -0.77% | +4.13% | +105.50% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | |
| -2.68% | +2.92% | +29.33% | +22.72% | 28.53B | |
| +0.05% | -1.64% | -8.14% | -11.37% | 24.34B | |
| Average | +1.12% | -0.53% | +43.19% | +105.76% | 39.05B | |
| Weighted average by Cap. | +0.12% | -0.84% | +56.96% | +138.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 1.4 1.25 1.16 1.06 2 134.97 2.02 14.09 5.46 69 5.27 5.16 221.44 |
| Net income | -11.65M -10.35M -9.66M -8.81M -16.61M -1.12B -16.76M -117M -45.31M -573M -43.75M -42.8M -1.84B | -2.91M -2.58M -2.41M -2.2M -4.15M -280M -4.19M -29.19M -11.31M -143M -10.92M -10.68M -459M |
| Net Debt | -2.59M -2.3M -2.15M -1.96M -3.7M -249M -3.73M -26.03M -10.09M -127M -9.74M -9.53M -409M | -2.86M -2.54M -2.37M -2.16M -4.07M -274M -4.11M -28.65M -11.1M -140M -10.72M -10.49M -450M |
Employees
1
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | US$0.4076 | +13.22% | 1,082 |
| 26-10-01 | US$0.3600 | -10.00% | 19,791 |
| 26-09-30 | US$0.4000 | 0.00% | 10,241 |
| 26-09-29 | US$0.4000 | -20.00% | 15,165 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATXI Stock
Select your edition
All financial news and data tailored to specific country editions
